| BRIUX | CSEIX | BRIUX / CSEIX | |
| Total Expense Ratio | 0.80 | 1.10 | 73% |
| Annual Report Gross Expense Ratio | 0.90 | 1.10 | 82% |
| Fund Existence | 8 years | 28 years | - |
| Gain YTD | 0.760 | 0.870 | 87% |
| Front Load | N/A | 5% | - |
| Min. Initial Investment | 5000000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 261M | 8.33B | 3% |
| Annual Yield % from dividends | 1.68 | 3.01 | 56% |
| Returns for 1 year | 4.03 | 3.25 | 124% |
| Returns for 3 years | 26.91 | 12.21 | 221% |
| Returns for 5 years | 28.18 | 17.99 | 157% |
| Returns for 10 years | N/A | 64.67 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SEMCX | 27.82 | 0.08 | +0.29% |
| SEI Mid-Cap F (SIMT) | |||
| PPSRX | 18.24 | 0.04 | +0.22% |
| Principal Large Cap Value III R5 | |||
| TISVX | 18.47 | 0.01 | +0.05% |
| Transamerica International Sm Cp Val I | |||
| FIDCX | 10.42 | -0.05 | -0.48% |
| JHancock Financial Industries C | |||
| THISX | 82.61 | -0.84 | -1.01% |
| T. Rowe Price Health Sciences I | |||